Non-breastfeeding Category Clarifications/Special considerations a) < 21 days 1 b) ≥ 21 days 1 … [Read more...]

Breastfeeding Category Clarifications/Special considerations a) < 6 weeks postpartum 3 Clarification: There is theoretical concern about the potential exposure of the neonate to DMPA/NET-EN during the first 6 weeks postpartum. In many settings, however, … [Read more...]

Non-breastfeeding Category Clarifications/Special considerations a) < 21 days 1 b) ≥ 21 days 1 … [Read more...]

Breastfeeding Category Clarifications/Special considerations a) < 6 weeks postpartum 2 b) ≥ 6 weeks to < 6 months postpartum (primarily breastfeeding) 1 c) ≥ 6 months postpartum 1 … [Read more...]

Non-breastfeeding Category     Clarifications/Special considerations a) < 21 days 1 b) ≥ 21 days 1 … [Read more...]

Breastfeeding Category     Clarifications/Special considerations a) < 6 weeks postpartum 2 b) ≥ 6 weeks to < 6 months postpartum (primarily breastfeeding) 1 c) ≥ 6 months postpartum 1 … [Read more...]

Non-breastfeeding Category Clarifications/Special considerations > 21 days to 42 days Clarification: For women up to 6 weeks postpartum with other risk factors for VTE, such as immobility, transfusion at delivery, BMI > 30 kg/m2, postpartum … [Read more...]

Breastfeeding Category Clarifications/Special considerations > 6 months postpartum 2 … [Read more...]

Non-breastfeeding Category Clarifications/Special considerations Non-breastfeeding Not eligible for method … [Read more...]

Breastfeeding Category Clarifications/Special considerations Breastfeeding <6 months postpartum There are no medical conditions in which the use of the LAM is restricted. ALL of the following three criteria must be met to ensure adequate protection from an … [Read more...]